Keywords: hybridon, unveils, oral, antisense, candidate, hiv, already

Hybridon Unveils Oral Antisense Candidate For HIV

Article | 21 August 1995

Print This

Hybridon already has an antisense drug targeting HIV infection called GEM 91 in clinical trials, but now believes it has gone ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in